Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Infinity Pharmaceuticals (INFIQ)
OTHER OTC:INFIQ
Holding INFIQ?
Track your performance easily
INFIQ Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume50.00
Average Volume (3M)31.50K
Market Cap
$91.00
Enterprise ValueN/A
Total Cash (Recent Filing)$92.06M
Total Debt (Recent Filing)$19.15M
Price to Earnings (P/E)―
Beta-5.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding90,761,080
10 Day Avg. Volume1,535
30 Day Avg. Volume31,498
Standard Deviation0.40
R-Squared0.03
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
INFIQ FAQ
What was Infinity Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Infinity Pharmaceuticals’s market cap?
Infinity Pharmaceuticals’s market cap is $91.00.
When is Infinity Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Infinity Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Infinity Pharmaceuticals overvalued?
According to Wall Street analysts Infinity Pharmaceuticals’s price is currently Overvalued.
Does Infinity Pharmaceuticals pay dividends?
Infinity Pharmaceuticals does not currently pay dividends.
What is Infinity Pharmaceuticals’s EPS estimate?
Infinity Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Infinity Pharmaceuticals have?
Infinity Pharmaceuticals has 90,761,080 shares outstanding.
What happened to Infinity Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Infinity Pharmaceuticals?
Currently, no hedge funds are holding shares in INFIQ
---
Company Description
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.
---
INFIQ Earnings Call
Q3 2022
0:00 / 0:00
---
Fate Therapeutics
―
Alaunos Therapeutics
―
Forte Biosciences
―
Corvus Pharmaceuticals
―
TuHURA Biosciences
―
Cyclerion Therapeutics
―
---